Alan R. Meyer's most recent trade in Opus Genetics Inc. was a trade of 2,679 Series A Warrant (right to buy) done . Disclosure was reported to the exchange on Nov. 19, 2020.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Opus Genetics Inc. | Alan R. Meyer | Director | Purchase of securities on an exchange or from another person at price $ 0.00 per share. | 19 Nov 2020 | 2,679 | 2,679 | - | - | Series A Warrant (right to buy) | |
| Opus Genetics Inc. | Alan R. Meyer | Director | Purchase of securities on an exchange or from another person at price $ 0.00 per share. | 19 Nov 2020 | 1,771 | 487,029 | - | - | Common Stock | |
| Opus Genetics Inc. | Alan R. Meyer | Director | Purchase of securities on an exchange or from another person at price $ 0.00 per share. | 19 Nov 2020 | 315 | 315 | - | - | Series B Warrant (right to buy) | |
| Opus Genetics Inc. | Alan R. Meyer | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Nov 2020 | 7,500 | 7,500 | - | - | Stock Option (right to buy) |